Marian Major

4.3k total citations · 2 hit papers
61 papers, 3.4k citations indexed

About

Marian Major is a scholar working on Hepatology, Epidemiology and Virology. According to data from OpenAlex, Marian Major has authored 61 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Hepatology, 44 papers in Epidemiology and 11 papers in Virology. Recurrent topics in Marian Major's work include Hepatitis C virus research (51 papers), Hepatitis B Virus Studies (40 papers) and HIV Research and Treatment (11 papers). Marian Major is often cited by papers focused on Hepatitis C virus research (51 papers), Hepatitis B Virus Studies (40 papers) and HIV Research and Treatment (11 papers). Marian Major collaborates with scholars based in United States, United Kingdom and France. Marian Major's co-authors include Stephen M. Feinstone, Charles M. Rice, S M Feinstone, Kathleen Mihalik, Geneviève Inchauspé, Montserrat Puig, Harel Dahari, Jane A. McKeating, Barbara Rehermann and Michelina Nascimbeni and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The Journal of Immunology.

In The Last Decade

Marian Major

60 papers receiving 3.3k citations

Hit Papers

Neutralizing antibody response during acute and chronic h... 2004 2026 2011 2018 2004 2006 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Neutralizing antibody response during acute and chronic hepatitis C virus infection
    2004 332 citations Carine Logvinoff, Marian Major et al. Proceedings of the National Academy of Sciences profile →
  2. Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro
    2006 331 citations Brett D. Lindenbach, Philip Meuleman et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marian Major United States 29 2.8k 2.2k 560 559 470 61 3.4k
Piero Pileri Italy 19 2.2k 0.8× 1.7k 0.8× 787 1.4× 768 1.4× 619 1.3× 29 3.7k
Domenico Rosa Italy 19 2.7k 1.0× 2.1k 0.9× 957 1.7× 545 1.0× 497 1.1× 31 3.7k
Michiko Miyamoto Japan 17 3.2k 1.2× 2.6k 1.2× 616 1.1× 346 0.6× 631 1.3× 21 3.7k
Erik Depla Belgium 23 1.8k 0.7× 1.6k 0.7× 697 1.2× 485 0.9× 482 1.0× 48 2.7k
Geneviève Inchauspé France 35 2.7k 1.0× 2.5k 1.1× 603 1.1× 795 1.4× 704 1.5× 91 4.1k
Kathleen Mihalik United States 22 1.9k 0.7× 1.6k 0.7× 378 0.7× 289 0.5× 334 0.7× 26 2.3k
Alexander W. Tarr United Kingdom 29 2.4k 0.9× 2.0k 0.9× 1.4k 2.5× 311 0.6× 427 0.9× 75 3.3k
Elisa Scarselli Italy 28 1.6k 0.6× 1.5k 0.7× 687 1.2× 850 1.5× 681 1.4× 73 3.2k
David Y. Chien United States 7 1.8k 0.6× 1.3k 0.6× 283 0.5× 493 0.9× 187 0.4× 10 2.1k
Michelina Nascimbeni United States 21 1.9k 0.7× 1.8k 0.8× 193 0.3× 1.6k 2.8× 332 0.7× 25 3.5k

Countries citing papers authored by Marian Major

Since Specialization
Citations

This map shows the geographic impact of Marian Major's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marian Major with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marian Major more than expected).

Fields of papers citing papers by Marian Major

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marian Major. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marian Major. The network helps show where Marian Major may publish in the future.

Co-authorship network of co-authors of Marian Major

This figure shows the co-authorship network connecting the top 25 collaborators of Marian Major. A scholar is included among the top collaborators of Marian Major based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marian Major. Marian Major is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jackson, Joseph W., Pravin R. Kaldhone, J.G. Anderson, et al.. (2024). 405 nm violet-blue light inactivates hepatitis C cell culture virus (HCVcc) in ex vivo human platelet concentrates and plasma. Scientific Reports. 14(1). 31540–31540.
2.
Mackesy‐Amiti, Mary Ellen, Alexander Gutfraind, Eric Tatara, et al.. (2024). Modeling of randomized hepatitis C vaccine trials: Bridging the gap between controlled human infection models and real-word testing. PNAS Nexus. 4(1). pgae564–pgae564. 1 indexed citations
3.
Lee, Myeongsang, Marian Major, & Huixiao Hong. (2023). Distinct Conformations of SARS-CoV-2 Omicron Spike Protein and Its Interaction with ACE2 and Antibody. International Journal of Molecular Sciences. 24(4). 3774–3774. 9 indexed citations
4.
5.
Kim, Jae‐Kwan, Clement A. Meseda, Krishnamurthy Konduru, et al.. (2022). EnhancedIn VitroandIn VivoPotency of a T Cell Epitope in the Ebola Virus Glycoprotein Following Amino Acid Replacement at HLA-A*02:01 Binding Positions. Journal of Virology. 96(18). e0116621–e0116621. 1 indexed citations
6.
Urbanowicz, Richard A., Johnathan D. Guest, Zhen–Yong Keck, et al.. (2021). An Antigenically Diverse, Representative Panel of Envelope Glycoproteins for Hepatitis C Virus Vaccine Development. Gastroenterology. 162(2). 562–574. 23 indexed citations
7.
Major, Marian, Alexander Gutfraind, Louis Shekhtman, et al.. (2018). Modeling of patient virus titers suggests that availability of a vaccine could reduce hepatitis C virus transmission among injecting drug users. Science Translational Medicine. 10(449). 35 indexed citations
8.
Major, Marian & Mansun Law. (2018). Detection of Antibodies to HCV E1E2 by Lectin-Capture ELISA. Methods in molecular biology. 1911. 421–432. 10 indexed citations
9.
Tan, Wendy G., et al.. (2017). Qualitative differences in cellular immunogenicity elicited by hepatitis C virus T-Cell vaccines employing prime-boost regimens. PLoS ONE. 12(7). e0181578–e0181578. 10 indexed citations
10.
Duan, Hongying, et al.. (2015). Reverse Engineering of Vaccine Antigens Using High Throughput Sequencing-enhanced mRNA Display. EBioMedicine. 2(8). 859–867. 5 indexed citations
11.
Feinstone, Stephen M., Dale J. Hu, & Marian Major. (2012). Prospects for Prophylactic and Therapeutic Vaccines Against Hepatitis C Virus. Clinical Infectious Diseases. 55(suppl_1). S25–S32. 43 indexed citations
12.
13.
Choi, You-kyung, Esther H. Chang, Kathleen F. Pirollo, et al.. (2009). T-cell vaccines that elicit effective immune responses against HCV in chimpanzees may create greater immune pressure for viral mutation. Vaccine. 27(19). 2594–2602. 26 indexed citations
14.
Lindenbach, Brett D., Philip Meuleman, Alexander Ploß, et al.. (2006). Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro. Proceedings of the National Academy of Sciences. 103(10). 3805–3809. 331 indexed citations breakdown →
15.
Dahari, Harel, Marian Major, Kathleen Mihalik, et al.. (2005). Mathematical modeling of primary hepatitis C infection: Noncytolytic clearance and early blockage of virion production. Gastroenterology. 128(4). 1056–1066. 96 indexed citations
16.
Logvinoff, Carine, Marian Major, David Oldach, et al.. (2004). Neutralizing antibody response during acute and chronic hepatitis C virus infection. Proceedings of the National Academy of Sciences. 101(27). 10149–10154. 332 indexed citations breakdown →
17.
18.
Major, Marian, et al.. (2003). Transcriptional upregulation of interferon-induced protein kinase, PKR, in breast cancer. Cancer Letters. 196(2). 207–216. 21 indexed citations
19.
Lerat, Hervé, Françoise Berby, Mary‐Anne Trabaud, et al.. (1996). Specific detection of hepatitis C virus minus strand RNA in hematopoietic cells.. Journal of Clinical Investigation. 97(3). 845–851. 228 indexed citations
20.
Major, Marian, Roger Eglin, & Andrew J. Easton. (1992). 3′ Terminal nucleotide sequence of human astrovirus type 1 and routine detection of astrovirus nucleic acid and antigens. Journal of Virological Methods. 39(1-2). 217–225. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Piero Pileri Breakdown of academic impact, for papers by Domenico Rosa Breakdown of academic impact, for papers by Michiko Miyamoto Breakdown of academic impact, for papers by Erik Depla Breakdown of academic impact, for papers by Geneviève Inchauspé Breakdown of academic impact, for papers by Kathleen Mihalik Breakdown of academic impact, for papers by Alexander W. Tarr Breakdown of academic impact, for papers by Elisa Scarselli Breakdown of academic impact, for papers by David Y. Chien Breakdown of academic impact, for papers by Michelina Nascimbeni
Rankless by CCL
2026